Literature DB >> 29275359

Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.

Ulrich H Weidle1, Fabian Birzele2, Gwen Kollmorgen1, Adam Nopora3.   

Abstract

Treatment of disseminated epithelial ovarian cancer (EOC) is an unmet medical need. Therefore, the identification along with preclinical and clinical validation of new targets is an issue of high importance. In this review we focus on microRNAs that mediate metastasis of EOC. We summarize up-regulated metastasis-promoting and down-regulated metastasis-suppressing microRNAs. We focus on preclinical in vitro and in vivo functions as well as their metastasis-related clinical correlations. Finally, we outline modalities for therapeutic intervention and critical issues of microRNA-based therapeutics in the context of metastatic EOC. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Antisense oligonucleotides; ascites fluid; epithelial mesenchymal transition; epithelial ovarian cancer; extracellular matrix; locked nucleic acids; mesothelial cells; peritoneal dissemination; review

Mesh：

Substances：

Year:  2018        PMID： 29275359      PMCID： PMC5822180          DOI： 10.21873/cgp.20061

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN： 1109-6535            Impact factor:   4.069


  151 in total

Review 1.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

2.  Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.

Authors:  Tingting Sun; Nicola Aceto; Kristen L Meerbrey; Jessica D Kessler; Chunshui Zhou; Ilenia Migliaccio; Don X Nguyen; Natalya N Pavlova; Maria Botero; Jian Huang; Ronald J Bernardi; Earlene Schmitt; Guang Hu; Mamie Z Li; Noah Dephoure; Steven P Gygi; Mitchell Rao; Chad J Creighton; Susan G Hilsenbeck; Chad A Shaw; Donna Muzny; Richard A Gibbs; David A Wheeler; C Kent Osborne; Rachel Schiff; Mohamed Bentires-Alj; Stephen J Elledge; Thomas F Westbrook
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

3.  Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis.

Authors:  Stefano Piccolo; Michelangelo Cordenonsi; Sirio Dupont
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

4.  Transduction of mechanical and cytoskeletal cues by YAP and TAZ.

Authors:  Georg Halder; Sirio Dupont; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2012-08-16       Impact factor: 94.444

Review 5.  miR-214 as a key hub that controls cancer networks: small player, multiple functions.

Authors:  Elisa Penna; Francesca Orso; Daniela Taverna
Journal:  J Invest Dermatol       Date:  2014-12-11       Impact factor: 8.551

Review 6.  The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.

Authors:  Yonghui Yu; Yu Wan; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

Review 7.  The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.

Authors:  Manav Korpal; Yibin Kang
Journal:  RNA Biol       Date:  2008 Jul-Sep       Impact factor: 4.652

Review 8.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

9.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

10.  Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer.

Authors:  Ridha Limame; Ken Op de Beeck; Steven Van Laere; Lieselot Croes; Annemieke De Wilde; Luc Dirix; Guy Van Camp; Marc Peeters; Olivier De Wever; Filip Lardon; Patrick Pauwels
Journal:  Oncoscience       Date:  2013-01-18
View more
  14 in total

Review 1.  The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.

Authors:  Ulrich H Weidle; Alexandra Epp; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2019 Jan-Feb       Impact factor: 4.069

Review 2.  MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

Review 3.  Identification of MicroRNAs With In Vivo Efficacy in Multiple Myeloma-related Xenograft Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

4.  MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer.

Authors:  Shaohua Ge; Haiyang Zhang; Ting Deng; Wu Sun; Tao Ning; Qian Fan; Yi Wang; Xinyi Wang; Qiumo Zhang; Zhengyang Zhou; Haiou Yang; Guoguang Ying; Yi Ba
Journal:  Invest New Drugs       Date:  2019-01-04       Impact factor: 3.850

Review 5.  Micro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma.

Authors:  Ulrich H Weidle; Simon AuslÄnder; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

Review 6.  microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Ulrich Brinkmann; Simon Auslaender
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

7.  The Influence of the Preoperative Status on the Risk of Postoperative Complications After Cytoreductive Surgery for Advanced-stage Ovarian Cancer.

Authors:  Laura Iliescu; Camelia Diaconu; Nicolae Bacalbasa; Irina Balescu; Mihai Dimitriu; Simona Dima; Mihaela Vilcu; Iulian Brezean
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

Review 8.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

Review 9.  Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

10.  MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.

Authors:  Cuihong Li; Shunrui Yu; Shanshan Wu; Ying Ni; Zixuan Pan
Journal:  Onco Targets Ther       Date:  2019-07-08       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.